NSAID enteropathy: could probiotics prevent it? (Q38033092)

27 August 2017

title

NSAID enteropathy: could probiotics prevent it? (English)

1 reference

27 August 2017

0 references

Massimo Montalto

1

1 reference

27 August 2017

Antonella Gallo

series ordinal

2

1 reference

27 August 2017

Antonio Gasbarrini

series ordinal

3

1 reference

27 August 2017

Raffaele Landolfi

series ordinal

4

1 reference

27 August 2017

publication date

9 August 2012

1 reference

Journal of Gastroenterology

27 August 2017

published in

1 reference

27 August 2017

volume

48

1 reference

27 August 2017

issue

6

1 reference

27 August 2017

page(s)

689-697

1 reference

Adverse effects of non-steroidal anti-inflammatory drugs (NSAIDs, aspirin and coxibs) on upper gastrointestinal tract

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0648-2

Present status and strategy of NSAIDs-induced small bowel injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0648-2

Video capsule endoscopy to prospectively assess small bowel injury with celecoxib, naproxen plus omeprazole, and placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0648-2

Visible small-intestinal mucosal injury in chronic NSAID users

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0648-2

Capsule endoscopic diagnosis of nonsteroidal antiinflammatory drug-induced enteropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0648-2

A quantitative analysis of NSAID-induced small bowel pathology by capsule enteroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0648-2

Adverse effects of drugs on small intestine and colon

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0648-2

COX-1 and 2, intestinal integrity, and pathogenesis of nonsteroidal anti-inflammatory drug enteropathy in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0648-2

Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0648-2

Serious lower gastrointestinal clinical events with nonselective NSAID or coxib use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0648-2

Intestinal permeability in the pathogenesis of NSAID-induced enteropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0648-2

Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0648-2

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0648-2

Review: The Biochemical Basis of Non-Steroidal Anti-Inflammatory Drug-Induced Damage to the Gastrointestinal Tract: A Review and a Hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0648-2

Resistance of germfree rats to indomethacin-induced intestinal lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0648-2

Intestinal mucosal damage caused by non-steroidal anti-inflammatory drugs: role of bile salts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0648-2

Heat shock protein 70-dependent protective effect of polaprezinc on acetylsalicylic acid-induced apoptosis of rat intestinal epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0648-2

Is non-steroidal anti-inflammaory drug (NSAID) enteropathy clinically more important than NSAID gastropathy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0648-2

Small bowel injury by low-dose enteric-coated aspirin and treatment with misoprostol: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0648-2

Prevention of nonsteroidal anti-inflammatory drug-induced small-intestinal injury by prostaglandin: a pilot randomized controlled trial evaluated by capsule endoscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0648-2

Efficacy of rebamipide for diclofenac-induced small-intestinal mucosal injuries in healthy subjects: a prospective, randomized, double-blinded, placebo-controlled, cross-over study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0648-2

Aspirin-induced small bowel injuries and the preventive effect of rebamipide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0648-2

Microbial flora in NSAID-induced intestinal damage: a role for antibiotics?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0648-2

Metronidazole reduces intestinal inflammation and blood loss in non-steroidal anti-inflammatory drug induced enteropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0648-2

Role of unbalanced growth of gram-negative bacteria in ileal ulcer formation in rats treated with a nonsteroidal anti-inflammatory drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0648-2

Non-steroidal anti-inflammatory drug-induced small intestinal damage is Toll-like receptor 4 dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0648-2

Probiotics in human medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0648-2

Probiotic bacteria enhance murine and human intestinal epithelial barrier function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0648-2

Probiotic bacteria and intestinal epithelial barrier function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0648-2

Lactobacillus casei prevents impaired barrier function in intestinal epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0648-2

Mechanisms of action of probiotics: recent advances

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0648-2

Functional modulation of enterocytes by gram-positive and gram-negative microorganisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0648-2

Probiotics reduce enterohemorrhagic Escherichia coli O157:H7- and enteropathogenic E. coli O127:H6-induced changes in polarized T84 epithelial cell monolayers by reducing bacterial adhesion and cytoskeletal rearrangements

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0648-2

Effect of probiotic strains on interleukin 8 production by HT29/19A cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0648-2

Commensal host-bacterial relationships in the gut

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0648-2

Prokaryotic regulation of epithelial responses by inhibition of IkappaB-alpha ubiquitination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0648-2

Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0648-2

Probiotic Lactobacillus casei strain Shirota prevents indomethacin-induced small intestinal injury: involvement of lactic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0648-2

Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0648-2

Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0648-2

Lactobacillus acidophilus protects tight junctions from aspirin damage in HT-29 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0648-2

Effect of Lactobacillus ingestion on the gastrointestinal mucosal barrier alterations induced by indometacin in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0648-2

Nonsteroidal anti-inflammatory drug-induced small-bowel lesions identified by double-balloon endoscopy: endoscopic features of the lesions and endoscopic treatments for diaphragm disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0648-2

VSL#3 Probiotic-Mixture Induces Remission in Patients with Active Ulcerative Colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0648-2

Lactobacillus rhamnosus GG exacerbates intestinal ulceration in a model of indomethacin-induced enteropathy

21 January 2018

1 reference

12 December 2020

Effect of prostaglandin on indomethacin-induced increased intestinal permeability in man.

1 reference

12 December 2020

Efficacy of Lactobacillus casei treatment on small bowel injury in chronic low-dose aspirin users: a pilot randomized controlled study

1 reference

12 December 2020

Temporal relationship between cyclooxygenase inhibition, as measured by prostacyclin biosynthesis, and the gastrointestinal damage induced by indomethacin in the rat

1 reference

12 December 2020

Nonsteroidal anti-inflammatory drug enteropathy in rats: role of permeability, bacteria, and enterohepatic circulation

1 reference

12 December 2020

Rebamipide has the potential to reduce the intensity of NSAID-induced small intestinal injury: a double-blind, randomized, controlled trial evaluated by capsule endoscopy

1 reference

12 December 2020

A new mechanism for anti-inflammatory actions of proton pump inhibitors--inhibitory effects on neutrophil-endothelial cell interactions

1 reference

12 December 2020

Prevention of beta-lactam-associated diarrhea by Saccharomyces boulardii compared with placebo

1 reference

12 December 2020

Lactobacillus and bifidobacterium in irritable bowel syndrome: Symptom responses and relationship to cytokine profiles

1 reference

12 December 2020

Effects of metronidazole and misoprostol on indomethacin-induced changes in intestinal permeability

1 reference

12 December 2020

The probiotic preparation, VSL#3 induces remission in patients with mild-to-moderately active ulcerative colitis

1 reference

12 December 2020

Proton pump inhibitors exacerbate NSAID-induced small intestinal injury by inducing dysbiosis

1 reference

12 December 2020

Successful treatment of relapsing Clostridium difficile colitis with Lactobacillus GG

1 reference

12 December 2020

Misoprostol reduces indomethacin-induced changes in human small intestinal permeability

1 reference

12 December 2020

Clinical trial: the effects of a probiotic mixture on non-steroidal anti-inflammatory drug enteropathy - a randomized, double-blind, cross-over, placebo-controlled study

1 reference

12 December 2020

NSAID-induced intestinal damage: are luminal bacteria the therapeutic target?

1 reference

12 December 2020

The biliary elimination and enterohepatic circulation of ibuprofen in rats

1 reference

12 December 2020

Prevention by lansoprazole, a proton pump inhibitor, of indomethacin -induced small intestinal ulceration in rats through induction of heme oxygenase-1.

1 reference

12 December 2020

Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans.

1 reference

12 December 2020

10.1007/S00535-012-0648-2

Identifiers

DOI

1 reference

27 August 2017

1 reference